Atai life sciences to present at the 41st annual canaccord genuity growth conference

Berlin, aug. 06, 2021 (globe newswire) -- atai life sciences n.v. (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it will participate in a fireside chat and one-on-one investor meetings at the canaccord genuity growth conference, to be held virtually from august 10-12, 2021.
ATAI Ratings Summary
ATAI Quant Ranking